Wells Fargo & Company Issues Pessimistic Forecast for Kezar Life Sciences (NASDAQ:KZR) Stock Price
Kezar Life Sciences (NASDAQ:KZR – Free Report) had its price target lowered by Wells Fargo & Company from $20.00 to $11.00 in a research note released on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. KZR has been the topic of a number of other reports. William Blair […]
More Stories
Record (LON:REC) Reaches New 1-Year Low – Here’s Why
Record plc (LON:REC – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock...
Insider Selling: Ambarella, Inc. (NASDAQ:AMBA) CTO Sells 1,757 Shares of Stock
Ambarella, Inc. (NASDAQ:AMBA – Get Free Report) CTO Leslie Kohn sold 1,757 shares of the company’s stock in a transaction...
Medical Facilities (TSE:DR) Hits New 12-Month High – Here’s Why
Medical Facilities Co. (TSE:DR – Get Free Report) shares reached a new 52-week high on Monday . The stock traded...
Imagine Lithium (CVE:ILI) Hits New 12-Month Low – Here’s Why
Imagine Lithium Inc. (CVE:ILI – Get Free Report) shares hit a new 52-week low on Monday . The company traded...
Identillect Technologies (CVE:ID) Hits New 12-Month Low – What’s Next?
Identillect Technologies Corp. (CVE:ID – Get Free Report)’s share price reached a new 52-week low during trading on Monday ....
Global Energy Metals (CVE:GEMC) Sets New 1-Year Low – Should You Sell?
Global Energy Metals Co. (CVE:GEMC – Get Free Report) shares hit a new 52-week low during trading on Monday ....